Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
Artigo em Russo | MEDLINE | ID: mdl-35904295

RESUMO

OBJECTIVE: To assess the effectiveness and safety of erenumab in real-life study. MATERIAL AND METHODS: 33 patients with episodic and chronic migraine (30 females, mean age 39.2±9.2, 3 males, mean age - 49.3±7.6) received erenumab 70 mg for each 3 months. Patients achieved a 50% reduction in the number of days with headache, pain intensity, duration, the number of days of acute medication use, effect on daily activity (HIT-6), side effects, neuropsychological testing (Beck Depression scale, Spielberger-Khanin questionnaire, Hospital Depression and Anxiety Scale) were assessed. RESULTS: During the first month of therapy, a 50% decrease in headache days was observed in 48% of patients, during the second - in 53% of patients, during the third - in 51.5% of patients (p<0.001), a reduce in pain intensity, HIT-6 score, duration of migraine attack was observed (p<0.005). A decrease in situational anxiety was revealed (Spielberger-Khanin questionnaire, p=0.02), but not depression. There was a decrease in the consumption of triptans (p<0.0005) and other analgesics (p=0.0018). 1 patient noted transient constipation. CONCLUSION: The effectiveness and safety of erenumab in the outpatient practice is shown.


Assuntos
Anticorpos Monoclonais Humanizados , Antagonistas do Receptor do Peptídeo Relacionado ao Gene de Calcitonina , Transtornos de Enxaqueca , Adulto , Anticorpos Monoclonais Humanizados/uso terapêutico , Antagonistas do Receptor do Peptídeo Relacionado ao Gene de Calcitonina/uso terapêutico , Método Duplo-Cego , Feminino , Cefaleia/induzido quimicamente , Cefaleia/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos de Enxaqueca/tratamento farmacológico , Neurologistas
2.
Vopr Pitan ; 87(4): 48-55, 2018.
Artigo em Russo | MEDLINE | ID: mdl-30570957

RESUMO

The questions of quality control and safety of milk raw materials has always been relevant for the dairy industry. One of the most common cattle infection is bovine leukemia (causative agent - BLV), which often occurs in conjunction with a closely related infection -bovine immunodeficiency (causative agent - BIV). These retroviruses are considered to be species-specific, so the key issue for the dairy industry is the nutritional and raw value of milk of infected cows (without clinical signs). Milk of infected with leukemia cows has changed physical and chemical properties and microbiological parameters, but it is allowed to be processed after a single pasteurization. Thus, there is a possibility of getting of the infected with retroviruses cow's milk into the bulk milk, which can affect the quality of the processed products. Characteristics of BlV-positive cow's milk have not yet been studied. The aim of the research was the study of influence of BLV- and BLV- BIV-infected cows' milk impurities (10, 30 и 50%) on organoleptic, physicochemical and microbiological parameters of produced kefir drink. It is revealed that with increasing the mass fraction of infected with retroviruses cows' milk, acidity of composite samples increased of 1-3 °T and total viable bacteria's count rose by 1-3 orders of magnitude, while the total protein in milk decreased by 0.05-0.95% contrasted with an increasing of milk fat content by 0.3-0.9%. However, these characteristics were within normal limits. In samples containing 50% of milk infected with retroviruses cows, coliforms were detected in 0.1 ml, and the rate of total viable bacteria's count exceeded the permissible limits. Therefore, microbiological characteristics are determination markers of dairy raw materials with the high content of milk of the infected with retroviruses cows. The kefir drink was produced from pasteurized samples. It was found that the acidity of the product was lower by 1-10 °T, while the processing time increased by 4-50%, correlating with the mass fraction of infected with retroviruses cows' milk, compared to control. When the mass fraction of infected with retroviruses cows' milk was 30 and 50%, the processed product had a heterogeneous consistency with flake clots. At the same time, the lactic-acid-producing bacterium count in kefir drink decreased by 2-3 orders, and mold and coliforms were found in it. Thus, the presence more than 10% of milk from infected with retroviruses cows in raw materials leads to a decrease in its technological properties, and dose 30 and 50% leads to non-compliance of the processed product with hygienic standards.


Assuntos
Laticínios/análise , Leucose Enzoótica Bovina/sangue , Microbiologia de Alimentos , Qualidade dos Alimentos , Inocuidade dos Alimentos , Vírus da Leucemia Bovina , Animais , Bovinos
3.
Artigo em Russo | MEDLINE | ID: mdl-29460901

RESUMO

AIM: To estimate pharmacokinetic variability of lamotrigine (LTG) and its clinical significance. MATERIAL AND METHODS: One hundred patients, including 74 women, aged from 18 to 77 years (38.23±14.37 years), with focal epilepsy were examined. Monotherapy with LTG was administered to 54 patients, duotherapy to 46 patients (LTG and valproic acid combination to 27 patients, LTG and liver enzymes inducers to 19 patients). Patients underwent procedures of therapeutic drug monitoring (TDM). Minimal (Cssmin) and maximal (Cssmax) steady-state LTG plasma concentrations, and concentration-to-weight ratio (CDR) were calculated. RESULTS AND CONCLUSION: In patients who used LTG in monotherapy, LTG Cssmin was 5.6±4.65 mg/l, Cssmax 7.59±5.54 mg/l. In the group that received LTG in combination with valproate, LTG Сssmin was 7.8 [5.4; 11.8] mg / l and Cssmax 11.4 [7.3; 15.3] mg/l. In the group that received LTG in combination with drug-inducers of glucuronidation, Cssmin was 2.5 [1.99; 4.32] mg/l, Cssmax 4.73 [2.91; 6.70] mg/l. Statistically significant differences in CDR parameter between groups with LTG monotherapy and duotherapy, both with inducer and with inhibitors, as well as between groups of duotherapy with inductors and with inhibitors were obtained. The results of the study indicate a pronounced pharmacokinetic variability of the LTG. Conducting TDM allows the establishment of individual therapeutic concentrations of LTG in blood plasma and setting a correction vector for antiepileptic therapy.


Assuntos
Anticonvulsivantes/farmacocinética , Epilepsias Parciais/tratamento farmacológico , Lamotrigina/farmacocinética , Adolescente , Adulto , Idoso , Anticonvulsivantes/sangue , Anticonvulsivantes/uso terapêutico , Monitoramento de Medicamentos , Quimioterapia Combinada , Epilepsias Parciais/sangue , Feminino , Humanos , Lamotrigina/sangue , Lamotrigina/uso terapêutico , Masculino , Pessoa de Meia-Idade , Ácido Valproico/sangue , Ácido Valproico/farmacocinética , Ácido Valproico/uso terapêutico , Adulto Jovem
4.
Ontogenez ; 45(6): 434-41, 2014.
Artigo em Russo | MEDLINE | ID: mdl-25739301

RESUMO

Using C-banding and FISH methods, the karyotype of MC1611 induced mutant of bread wheat, which develop additional spikelets at a rachis node (trait "supernumerary spikelets") was characterized. It was determined that the mutant phenotype is not associated with aneuploidy and major chromosomal rearrangements. The results of genetic analysis showed that supernumerary spikelets of the line are caused by a mutation of the single bh-D. 1 gene, influenced by the genetic background. The mutation causes abnormalities of inflorescence morphogenesis associated with the development of ectopic spikelet meristems in place of floral meristems in the basal part of the spikelets, causing the appearance of additional spikes at a rachis node. The mutant phenotype suggests that the Bh-D gene determines the fate of the lateral meristem in ear, which develops as floral meristem and gives rise to floral organs in wild-type inflorescences. In the Bh-D. 1 mutant, the establishing identity is impaired. The characterized mutant can be used in further studies on molecular genetic basis of development of wheat inflorescence.


Assuntos
Cromossomos de Plantas , Flores , Meristema , Morfogênese/genética , Mutação , Triticum , Bandeamento Cromossômico , Cromossomos de Plantas/genética , Cromossomos de Plantas/metabolismo , Flores/embriologia , Flores/genética , Cariótipo , Meristema/genética , Meristema/metabolismo , Triticum/embriologia , Triticum/genética
5.
Angiol Sosud Khir ; 17(4): 55-61, 2011.
Artigo em Russo | MEDLINE | ID: mdl-22616230

RESUMO

OBJECTIVE: To evaluate immediate and long-term clinical and ultrasound efficacy of proximal vertebral arteries stenting. We studied 74 subjects (age 61+/-10 years) who underwent transluminal balloon angioplasty with stenting of vertebral arteries (77 vessels). Technical success (i.e., residual stenosis < 20%) was achieved in 95% patients. No events (acute stroke, myocardial infarction, or death) were recorded during the procedure or in early postoperative period. Clinical improvement was seen in 81% patients presented with symptoms of vetebrobasilar insufficiency at the baseline (n = 52). Sixty six patients (89%) were followed up in the late postoperative period (6 to 54 months after the intervention). No events of acute stroke were recorded in the vertebrobasilar circulation. Relapse of vertebrobasilar symptoms after temporary improvement was seen in 13% patients. Stent restenosis/occlusion was diagnosed in 36% patients although no relationship was revealed between the alteration of stent patency and relapse of clinical symptoms. Restenosis correlated with initial stenosis of > or = 70% (p < 0.05) and type of stent material. Use of cobalt chromium stents was associated with 2-fold decrease of restenosis rate vs non cobalt chromium stents (24% vs 50%, respectively, p < 0.05). Therefore, stenting of proximal vertebral arteries yields good technical and clinical results. High restenosis rate is a major problem of endovascular treatment of atherosclerosis and needs further evaluation.


Assuntos
Angioplastia com Balão , Implante de Prótese Vascular , Constrição Patológica/etiologia , Falha de Prótese , Stents , Insuficiência Vertebrobasilar , Idoso , Angiografia/métodos , Angioplastia com Balão/efeitos adversos , Angioplastia com Balão/métodos , Prótese Vascular/normas , Implante de Prótese Vascular/efeitos adversos , Implante de Prótese Vascular/instrumentação , Implante de Prótese Vascular/métodos , Ligas de Cromo/uso terapêutico , Análise de Falha de Equipamento , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Monitorização Intraoperatória/métodos , Avaliação de Processos e Resultados em Cuidados de Saúde/estatística & dados numéricos , Stents/efeitos adversos , Stents/normas , Resultado do Tratamento , Ultrassonografia Doppler em Cores/métodos , Grau de Desobstrução Vascular , Artéria Vertebral/fisiopatologia , Artéria Vertebral/cirurgia , Insuficiência Vertebrobasilar/diagnóstico , Insuficiência Vertebrobasilar/fisiopatologia , Insuficiência Vertebrobasilar/terapia
6.
J Phys Condens Matter ; 21(41): 415502, 2009 Oct 14.
Artigo em Inglês | MEDLINE | ID: mdl-21693989

RESUMO

Single-crystalline films of Lu(3)Al(5)O(12):Bi, prepared by the liquid phase epitaxy method from the melt-solution based on Bi(2)O(3) flux, have been studied at 4.2-400 K by time-resolved luminescence spectroscopy methods. Their emission spectra consist of two types of bands with strongly different characteristics. The ultraviolet emission band consists of two components, arising from the electronic transitions which correspond to the [Formula: see text] and [Formula: see text] transitions in a free Bi(3+) ion. At low temperatures, mainly the lower-energy component of this emission is observed, having the decay time∼10(-3) s at T<100 K and arising from the metastable (3)P(0) level. At T>100 K, the higher-energy emission component appears, arising from the thermally populated emitting (3)P(1) level. The visible emission spectrum consists of two dominant strongly overlapped broad bands with large Stokes shifts. At 4.2 K, their decay times are ∼10(-5) s and decrease with increasing temperature. Both of the visible emission bands are assumed to have an exciton origin. The lower-energy band is ascribed to an exciton, localized near a single Bi(3+) ion. The higher-energy band shows a stronger intensity dependence on the Bi(3+) content and is assumed to arise from an exciton localized near a dimer Bi(3+) center. The origin and structure of the corresponding excited states is considered and the processes, taking place in the excited states, are discussed.

7.
Radiat Prot Dosimetry ; 119(1-4): 164-7, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16581927

RESUMO

A systematic study of photothermally stimulated defects creation processes is carried out by the thermally stimulated luminescence (TSL) method for a large number of undoped and doped PbWO4 crystals under irradiation at 80-180 K in the 3.4-4.3 eV energy range. The activation energy Ea for the regular exciton state disintegration is found to be approximately 0.1 eV. For defect-related states disintegration, Ea varies in the crystals studied from 0.03 to 0.36 eV. The origin of the defect-related states is discussed. The conclusion is made that not only a release of charge carriers but also charge transfer processes take place under UV irradiation of PbWO4 crystals.


Assuntos
Cristalização/métodos , Dosimetria Termoluminescente/métodos , Compostos de Tungstênio/química , Compostos de Tungstênio/efeitos da radiação , Raios Ultravioleta , Relação Dose-Resposta à Radiação , Teste de Materiais , Doses de Radiação , Compostos de Tungstênio/análise
8.
Angiol Sosud Khir ; 10(4): 17-21, 2004.
Artigo em Russo | MEDLINE | ID: mdl-15627130

RESUMO

The problem of asymptomatic stenoses of the internal carotid artery (ICA) has become a matter of great concern especially after ultrasonography of the great arteries of the head and, first of all, duplex scanning were introduced on a wide-scale basis into practice of the physicians of varying specialties. The growing population of patients with asymptomatic stenoses raises the problem of their further management with the purpose of preventing ischemic stroke. In connection with significant advances in vascular surgery carotid endarterectomy (CEE) has assumed an increasing role in the treatment of carotid stenoses. In spite of the fact that the efficacy of CEE for hemodynamically significant stenoses has already been proven, nevertheless at present there is no final decision concerning the problem of the indications for surgical treatment of patients with asymptomatic stenoses. The aim of this study was to assess in detail the vascular system of the brain in patients presenting with stenosis greater than 60% and ICA thrombosis, to distinguish the groups at a high risk for stroke and to delineate the treatment measures for its prevention.


Assuntos
Trombose das Artérias Carótidas/diagnóstico por imagem , Trombose das Artérias Carótidas/fisiopatologia , Artéria Carótida Interna/fisiopatologia , Estenose das Carótidas/diagnóstico por imagem , Estenose das Carótidas/fisiopatologia , Idoso , Trombose das Artérias Carótidas/cirurgia , Artéria Carótida Interna/cirurgia , Estenose das Carótidas/cirurgia , Diagnóstico Diferencial , Endarterectomia das Carótidas , Feminino , Hemodinâmica/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Ultrassonografia Doppler Dupla
9.
Med Tekh ; (5): 58-9, 1981.
Artigo em Russo | MEDLINE | ID: mdl-7300636

RESUMO

A cryogenic ENT applicator, model K-22 has been designed and recommended for clinical use. The applicator unit comprises an independent container filled with liquid nitrogen and connected to a cooling tip 2 mm in diameter by capillary tubes. The applicator is used for the destruction of neoplasms by cryogenic action in hardly accessible places in the aural, pharyngeal and nasal cavities. The applicator is easy to sue, has a small size and weight and allows a good survey of the operative field. It can be used in hospital and in outpatient clinics.


Assuntos
Criocirurgia/instrumentação , Otorrinolaringopatias/cirurgia , Humanos , U.R.S.S.
11.
Med Tekh ; (1): 32-4, 1977.
Artigo em Russo | MEDLINE | ID: mdl-870787

RESUMO

A cryoprobe with an interchangeable container (vessel) holding the cryoprobe has been designed, this enabling it to dispense with the use of hoses to deliver the coolant to and remove it from the Dewar vessel and the vacuum pump. The cryogenic action provided for by a single ampoule lasts 5 minutes. The small diameter of the cryoprobe makes for a minimal traumatization of the surrounding structures, while the absence of connecting hoses makes for its easy handling.


Assuntos
Criocirurgia/instrumentação , Neurocirurgia/instrumentação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...